30S bacterial ribosomal subunit aminoacyl-tRNA binding site (30S A-site)

The 30S bacterial ribosomal subunit A-site, or aminoacyl-tRNA binding site, is a critical functional region within the small subunit of the bacterial ribosome, primarily composed of 16S ribosomal RNA (rRNA) [PMID: 11586344]. It serves as the decoding center where the anticodon of an incoming aminoacyl-tRNA is matched with the codon of the messenger RNA (mRNA) to ensure translational fidelity [PMID: 10733502]. This site is the primary target for several major classes of antibiotics, most notably aminoglycosides and tetracyclines [StatPearls: Aminoglycosides]. Aminoglycosides bind to the A-site and induce a conformational change in the 16S rRNA, which causes the ribosome to misread mRNA codons and incorporate incorrect amino acids into the growing polypeptide chain [PMID: 11130712]. This leads to the production of mistranslated proteins that can damage the bacterial cell membrane, ultimately resulting in cell death. Tetracyclines, in contrast, bind to the A-site and physically block the entry of aminoacyl-tRNA, thereby inhibiting the elongation phase of protein synthesis [PMID: 11586344]. Because the bacterial A-site is structurally distinct from the eukaryotic cytosolic ribosome, these drugs exhibit selective toxicity against bacteria. However, similarities between the bacterial A-site and the human mitochondrial ribosomal A-site can lead to clinical complications such as ototoxicity and nephrotoxicity [PMID: 12634337]. Resistance to drugs targeting this site often arises through mutations in the 16S rRNA or the expression of methyltransferase enzymes that modify the A-site to prevent drug binding [PMID: 17051058].

Other names

A-siteDecoding center16S rRNA A-siteAminoacyl-tRNA binding site30S decoding site

Inhibition of bacterial protein synthesis by interfering with the decoding of mRNA or sterically blocking the entry of aminoacyl-tRNA into the A-site.